{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:36:40Z","timestamp":1779889000921,"version":"3.53.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ibroneuroscience.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.neuroscience.2024.11.003","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T22:08:58Z","timestamp":1730758138000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Unveiling the veil of adipokines: A meta-analysis and systematic review in amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"563","author":[{"given":"Hamid","family":"Abbasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Jourabchi-ghadim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Asgarzade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobin","family":"Mirshekari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrangiz","family":"Ebrahimi-Mameghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2024.11.003_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2012.12.008","article-title":"The adipose tissue as an endocrine organ","author":"Adamczak","year":"2013","journal-title":"Seminars in Nephrology"},{"issue":"3","key":"10.1016\/j.neuroscience.2024.11.003_b0010","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/acn3.721","article-title":"Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"6","author":"Ahmed","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"7206","key":"10.1016\/j.neuroscience.2024.11.003_b0015","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature07181","article-title":"UCP2 mediates ghrelin\u2019s action on NPY\/AgRP neurons by lowering free radicals","volume":"454","author":"Andrews","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2024.11.003_b0020","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.neuroscience.2024.11.003_b0025","doi-asserted-by":"crossref","unstructured":"Beller, E. M., Glasziou, P. P., Altman, D. G., Hopewell, S., Bastian, H., Chalmers, I., G\u00f8tzsche, P. C., Lasserson, T., Tovey, D., & Group, P. f. A. (2013). PRISMA for abstracts: reporting systematic reviews in journal and conference abstracts. PLoS medicine, 10(4), e1001419.","DOI":"10.1371\/journal.pmed.1001419"},{"key":"10.1016\/j.neuroscience.2024.11.003_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-0861-2","article-title":"Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?","volume":"14","author":"Bossolasco","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.neuroscience.2024.11.003_b0035","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/jnnp-2015-310471","article-title":"Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China","volume":"86","author":"Chen","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.003_b0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","article-title":"Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications","volume":"17","author":"Chia","year":"2018","journal-title":"The Lancet Neurology"},{"issue":"2","key":"10.1016\/j.neuroscience.2024.11.003_b0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/eji.201646423","article-title":"Nutritional effects on T-cell immunometabolism","volume":"47","author":"Cohen","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neuroscience.2024.11.003_b0050","article-title":"Serum Adiponectin alterations in Amyotrophic Lateral Sclerosis and frontotemporal dementia","author":"Doretti","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuroscience.2024.11.003_b0055","doi-asserted-by":"crossref","first-page":"1177431","DOI":"10.3389\/fnins.2023.1177431","article-title":"Risk factors of amyotrophic lateral sclerosis: a global meta-summary","volume":"17","author":"Duan","year":"2023","journal-title":"Front. Neurosci."},{"issue":"7109","key":"10.1016\/j.neuroscience.2024.11.003_b0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.neuroscience.2024.11.003_b0065","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jaci.2007.10.018","article-title":"Adiponectin and inflammation: consensus and controversy","volume":"121","author":"Fantuzzi","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.11.003_b0070","doi-asserted-by":"crossref","first-page":"e35594","DOI":"10.1371\/journal.pone.0035594","article-title":"Acute leptin treatment enhances functional recovery after spinal cord injury","volume":"7","author":"Fern\u00e1ndez-Martos","year":"2012","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.neuroscience.2024.11.003_b0075","doi-asserted-by":"crossref","first-page":"10305","DOI":"10.3390\/ijms221910305","article-title":"Alterations in leptin signaling in amyotrophic lateral sclerosis (ALS)","volume":"22","author":"Ferrer-Donato","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.neuroscience.2024.11.003_b0080","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.peptides.2011.09.019","article-title":"Role of ghrelin system in neuroprotection and cognitive functions: implications in Alzheimer's disease","volume":"32","author":"Gahete","year":"2011","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.003_b0085","first-page":"1","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"7","key":"10.1016\/j.neuroscience.2024.11.003_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131512","article-title":"Blood cell palmitoleate-palmitate ratio is an independent prognostic factor for amyotrophic lateral sclerosis","volume":"10","author":"Henriques","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2024.11.003_b0095","first-page":"343","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","author":"Higgins","year":"2011","journal-title":"bmj"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.003_b0100","doi-asserted-by":"crossref","first-page":"e2463","DOI":"10.2196\/ijmr.2463","article-title":"Severe loss of appetite in amyotrophic lateral sclerosis patients: online self-assessment study","volume":"2","author":"Holm","year":"2013","journal-title":"Interactive J. Med. Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.003_b0105","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16052","article-title":"Associations of postprandial ghrelin, liver-expressed antimicrobial peptide 2 and leptin levels with body composition, disease progression and survival in patients with amyotrophic lateral sclerosis","volume":"31","author":"Howe","year":"2024","journal-title":"Eur. J. Neurol."},{"issue":"19","key":"10.1016\/j.neuroscience.2024.11.003_b0110","doi-asserted-by":"crossref","first-page":"14684","DOI":"10.3390\/ijms241914684","article-title":"The role of adipokines in the pathologies of the central nervous system","volume":"24","author":"Huber","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.11.003_b0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jmedgenet-2016-104271","article-title":"Genetics insight into the amyotrophic lateral sclerosis\/frontotemporal dementia spectrum","volume":"54","author":"Ji","year":"2017","journal-title":"J. Med. Genet."},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2024.11.003_b0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/prca.201100052","article-title":"Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders","volume":"6","author":"Lehr","year":"2012","journal-title":"Proteomics\u2013Clin. App."},{"issue":"7","key":"10.1016\/j.neuroscience.2024.11.003_b0125","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/acn3.51580","article-title":"Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis","volume":"9","author":"Li","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.11.003_b0130","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","article-title":"Epidemiology of amyotrophic lateral sclerosis: an update of recent literature","volume":"32","author":"Longinetti","year":"2019","journal-title":"Curr. Opin. Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.003_b0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/oby.2002.3","article-title":"Leptin's sexual dimorphism results from genotype by sex interactions mediated by testosterone","volume":"10","author":"Martin","year":"2002","journal-title":"Obes. Res."},{"key":"10.1016\/j.neuroscience.2024.11.003_b0140","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s13760-017-0798-3","article-title":"CSF concentrations of adipsin and adiponectin in patients with amyotrophic lateral sclerosis","volume":"117","author":"Mart\u00ednez","year":"2017","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.neuroscience.2024.11.003_b0145","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & Group*, P. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine, 151(4), 264-269.","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"10.1016\/j.neuroscience.2024.11.003_b0150","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jns.2017.08.1597","article-title":"Changes in plasma ghrelin levels accompanying a decrease in muscle volume can affect the prognosis of amyotrophic lateral sclerosis patients","volume":"381","author":"Nagaoka","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2024.11.003_b0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neures.2021.11.003","article-title":"Decreased plasma ghrelin in male ALS patients is associated with poor prognosis","volume":"177","author":"Nagaoka","year":"2022","journal-title":"Neurosci. Res."},{"issue":"24","key":"10.1016\/j.neuroscience.2024.11.003_b0160","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1161\/01.CIR.0000149746.62908.BB","article-title":"Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure","volume":"110","author":"Nagaya","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.003_b0165","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1038\/s41598-017-04706-5","article-title":"Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis\u2013results from a population-based ALS registry in Germany","volume":"7","author":"Nagel","year":"2017","journal-title":"Sci. Rep."},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2024.11.003_b0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2015.06.053","article-title":"Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis","volume":"357","author":"Ngo","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.neuroscience.2024.11.003_b0175","doi-asserted-by":"crossref","first-page":"e12938","DOI":"10.1111\/jne.12938","article-title":"Ghrelin as a treatment for amyotrophic lateral sclerosis","volume":"33","author":"Ngo","year":"2021","journal-title":"J. Neuroendocrinol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.003_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0530-x","article-title":"Secret talk between adipose tissue and central nervous system via secreted factors\u2014an emerging frontier in the neurodegenerative research","volume":"13","author":"Parimisetty","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.neuroscience.2024.11.003_b0185","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.3390\/ijms24065065","article-title":"Distinct plasma immune profile in ALS implicates sTNFR-II in pAMPK\/leptin homeostasis","volume":"24","author":"Picher-Martel","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2024.11.003_b0190","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/17482960902822960","article-title":"Impaired glucose tolerance in patients with amyotrophic lateral sclerosis","volume":"11","author":"Pradat","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.11.003_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2012.08.036","article-title":"Functional and structural features of adipokine family","volume":"61","author":"Raucci","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.neuroscience.2024.11.003_b0200","doi-asserted-by":"crossref","unstructured":"Rosenbohm, A., Nagel, G., Peter, R. S., Brehme, T., Koenig, W., Dupuis, L., Rothenbacher, D., Ludolph, A. C., & Group, A. R. S. (2018). Association of serum retinol-binding protein 4 concentration with risk for and prognosis of amyotrophic lateral sclerosis. JAMA neurology, 75(5), 600-607.","DOI":"10.1001\/jamaneurol.2017.5129"},{"issue":"7","key":"10.1016\/j.neuroscience.2024.11.003_b0205","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/acn3.77","article-title":"Disease modifying effect of adiponectin in model of \u03b1-synucleinopathies","volume":"1","author":"Sekiyama","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neuroscience.2024.11.003_b0210","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"issue":"10107","key":"10.1016\/j.neuroscience.2024.11.003_b0215","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"Van Es","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2024.11.003_b0220","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00401-018-1835-x","article-title":"Energy metabolism in ALS: an underappreciated opportunity?","volume":"135","author":"Vandoorne","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.11.003_b0225","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/brain\/aww004","article-title":"Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis","volume":"139","author":"Vercruysse","year":"2016","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neuroscience.2024.11.003_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaac.2013.12.025","article-title":"Child abuse, depression, and methylation in genes involved with stress, neural plasticity, and brain circuitry","volume":"53","author":"Weder","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"9","key":"10.1016\/j.neuroscience.2024.11.003_b0235","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.bbadis.2015.06.019","article-title":"The emerging role of adiponectin in cerebrovascular and neurodegenerative diseases","volume":"1852","author":"Yang","year":"2015","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"10.1016\/j.neuroscience.2024.11.003_b0240","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pneurobio.2016.05.004","article-title":"ALS: A bucket of genes, environment, metabolism and unknown ingredients","volume":"142","author":"Zufir\u00eda","year":"2016","journal-title":"Prog. Neurobiol."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224005852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224005852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T05:33:29Z","timestamp":1734586409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452224005852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":48,"alternative-id":["S0306452224005852"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.11.003","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the veil of adipokines: A meta-analysis and systematic review in amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}